We witnessed tremendous growth in reach52, improving health outcomes for residents living in our partner communities, and creating even greater value for our clients and funders. We implemented a total of 13 campaigns across 2500 communities and expanded to two new countries – South Africa and Myanmar. Read on for our milestones, highlights, impact and case studies in underserved emerging communities and hear from the humans of reach52: in-depth perspectives from a resident, Agent and a government doctor!
“The hardest part was everyone telling me it was impossible… the
biggest challenge was being thick-skinned and playing to win.” – Our CEO Edward Booty shares with Tatler Asia Group about his journey building and growing reach52.
Read the article here.
Delighted to be featured in The Star, one of the largest news publications in Kenya for our work with Bayer to close the nutrient gap in Kenya and South Africa.
👩🏽🏫 We train Community Health Volunteers (CHV) in rural communities to use the reach52 app and MUAC tape to log health data and assess nutritional status
🗣 A resident of Nyangoro village, Rangwe, summed up this process: “The CHV was knowledgeable on what he was doing. After the screening, he gave us advice on maintaining a balanced diet, types of locally available food that we should eat to avoid malnutrition, as well as the possible complications and diseases that may result from malnutrition.”
Read more about how we are creating long-term scalable impact in these communities.
Along with over 40 organisations, reach52 has signed the Zero Health Gaps Pledge – a commitment to advance health equity and eliminate disparities in health and well-being outcomes.
The difference in average life expectancy at birth between high and low income countries is glaring at 78 and 64 years respectively. At the most extreme, Japan and the Central African Republic have a difference in average life expectancy of over 30 years. Global climate and health crises, including the COVID-19 pandemic, have heightened both the severity of these inequities and the potential consequences of inaction. The Zero Health Gaps Pledge is a pledge to take action today so we can reverse this reality tomorrow.
The gap in years of human potential lost can be reclaimed by transforming the way organisations work, including the private sector. Leaders across industries can help drive this change by placing health equity at the core of their decision making for strategy, operations, and investments
Join us and take the pledge: https://lnkd.in/eumWNFBX
We are proud to be featured in the new World Economic Forum
report for our work on targeted decentralisation in delivering healthcare services to underserved communities.
The Global Health & Healthcare Strategic Outlook reflects on key learnings from the past years and lays a vision for health and healthcare in 2035, formed of four main strategic pillars with equity as the foundation goal.
⛑ Equitable access and outcomes
⛑ Healthcare system transformation
⛑ Technology and innovation
⛑ Environmental sustainability
Using case studies from across the world, it identifies a range of levers available to public and private stakeholders to overcome existing barriers
🔎 Cross-industry collaboration
🔎 Digitalisation, artificial intelligence and big data
🔎 Global collaboration
🔎 Policy and advocacy
🔎 Public-private partnerships
🔎 Innovative funding models
🔎 Patient empowerment
🔎 Targeted/selective decentralisation
Have a quick read below! Head here for the full report 💡
Thrilled to be selected to join the Million Lives Collective (MLC), an initiative that recognises and raises awareness of innovators and social entrepreneurs in #globaldev #millionlives #healthequity
Check it out here 💡 https://lnkd.in/gaXZVupu
Our CEO Edward Booty speaks to Amy Hung from McKinsey & Company about how he became an innovator in healthcare, the biggest opportunities and obstacles for healthcare innovation, and what he wished he had known when he first started as an entrepreneur.
Read the interview here.
CEO of Sanofi, Paul Hudson, cites partnership with reach52 as an example of the importance of working with startups on-the-ground to improve health outcomes in developing countries
“Increasing access to health care in low-income countries in a meaningful way requires more than providing them with low-cost medicines. We need a new framework of cooperation to address the myriad interconnected challenges we face as we adapt to new technologies and nurture local innovation. As pharmaceutical companies, our job is to disrupt our own thinking and encourage on-the-ground innovators.”
Read the full article here.
What are pharmaceutical companies doing to expand access to insulin, and how can efforts be scaled up?
The number of people with diabetes worldwide is expected to reach 643 million by 2030, and 783 million by 2045 – rising most rapidly in low-and-middle income countries (LMICs), where there is stark inequity in access to insulin.
This report highlights the urgent actions that companies, governments and their partners can take to provide patients in resource-limited settings with the choice of treatment they deserve.
These include
– Scaling up and diversifying the global insulin market
– The unrealised potential of biosimilar insulins in expanding access to insulin
Biocon aims for its biosimilar insulins to reach one in five insulin-dependent people with diabetes globally. To achieve this, they launched their ‘Mission 10 cents’ strategy, committing to offer its human insulins for less than USD 10 cents per day from vials directly sourced from Biocon Biologics by governments in LMICs.
The programme has been launched in the Philippines, in partnership with reach52, covering programme implementation and logistics required to provide last-mile delivery of insulins at a price aligned to Biocon’s Mission 10 cents.
Download the full report and read more about the strategies to overcome barriers to access, areas where progress has been made, and opportunities for future action.
Jointly curated by Stewardship Asia Centre (SAC), the INSEAD Hoffmann Global Institute for Business and Society and The Straits Times, SL25 is an annual listing of initiatives from 25 for-profit organisations that have shown Steward Leadership excellence within the Asia-Pacific region.
Steward Leadership excellence demands genuine desire and persistence to create a collective better future for stakeholders, society, future generations and the environment.
Big congrats to all the other honourees 🎉
Angkas | Avtar The Power of Diversity | Ayala Corporation | BNP Paribas Asset Management | CapitaLand | City Developments Limited | DBS Bank | Faber-Castell Group | Farm Fresh Berhad | Foreword | Genashtim | GUAVA | Mandai Wildlife Group | Marico Limited | Mirvac | Noburo Wealth-Being | OCBC Bank | Sunway Group | Tata Consultancy Services | THAI WAH PUBLIC COMPANY LIMITED | The Social Kitchen | UAL Biotech | UBS | UOB
25 firms from Singapore and Asia Pacific lauded for doing well by doing good.